nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR1B—dura mater—ankylosing spondylitis	0.071	0.449	CbGeAlD
Pramipexole—HTR1D—dura mater—ankylosing spondylitis	0.0688	0.434	CbGeAlD
Pramipexole—HTR2A—vertebral column—ankylosing spondylitis	0.0103	0.0648	CbGeAlD
Pramipexole—HTR2B—tendon—ankylosing spondylitis	0.00278	0.0176	CbGeAlD
Pramipexole—ADRA2C—tendon—ankylosing spondylitis	0.00219	0.0138	CbGeAlD
Pramipexole—ADRA2A—tendon—ankylosing spondylitis	0.00175	0.011	CbGeAlD
Pramipexole—HTR2A—tendon—ankylosing spondylitis	0.00148	0.00938	CbGeAlD
Pramipexole—Infection—Triamcinolone—ankylosing spondylitis	0.0005	0.000593	CcSEcCtD
Pramipexole—Sweating—Methotrexate—ankylosing spondylitis	0.000499	0.000593	CcSEcCtD
Pramipexole—Infection—Methylprednisolone—ankylosing spondylitis	0.000498	0.000592	CcSEcCtD
Pramipexole—Haematuria—Methotrexate—ankylosing spondylitis	0.000496	0.00059	CcSEcCtD
Pramipexole—Shock—Triamcinolone—ankylosing spondylitis	0.000495	0.000588	CcSEcCtD
Pramipexole—Insomnia—Prednisolone—ankylosing spondylitis	0.000495	0.000588	CcSEcCtD
Pramipexole—Alopecia—Prednisone—ankylosing spondylitis	0.000494	0.000587	CcSEcCtD
Pramipexole—Shock—Methylprednisolone—ankylosing spondylitis	0.000494	0.000586	CcSEcCtD
Pramipexole—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000492	0.000585	CcSEcCtD
Pramipexole—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000492	0.000585	CcSEcCtD
Pramipexole—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000491	0.000584	CcSEcCtD
Pramipexole—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000491	0.000584	CcSEcCtD
Pramipexole—Epistaxis—Methotrexate—ankylosing spondylitis	0.000491	0.000583	CcSEcCtD
Pramipexole—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000491	0.000583	CcSEcCtD
Pramipexole—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000491	0.000583	CcSEcCtD
Pramipexole—Mental disorder—Prednisone—ankylosing spondylitis	0.00049	0.000582	CcSEcCtD
Pramipexole—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00049	0.000582	CcSEcCtD
Pramipexole—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000487	0.000579	CcSEcCtD
Pramipexole—Erythema—Prednisone—ankylosing spondylitis	0.000487	0.000578	CcSEcCtD
Pramipexole—Malnutrition—Prednisone—ankylosing spondylitis	0.000487	0.000578	CcSEcCtD
Pramipexole—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000486	0.000578	CcSEcCtD
Pramipexole—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000485	0.000576	CcSEcCtD
Pramipexole—Convulsion—Betamethasone—ankylosing spondylitis	0.000484	0.000575	CcSEcCtD
Pramipexole—Convulsion—Dexamethasone—ankylosing spondylitis	0.000484	0.000575	CcSEcCtD
Pramipexole—Hypertension—Dexamethasone—ankylosing spondylitis	0.000483	0.000573	CcSEcCtD
Pramipexole—Hypertension—Betamethasone—ankylosing spondylitis	0.000483	0.000573	CcSEcCtD
Pramipexole—Myalgia—Dexamethasone—ankylosing spondylitis	0.000476	0.000565	CcSEcCtD
Pramipexole—Myalgia—Betamethasone—ankylosing spondylitis	0.000476	0.000565	CcSEcCtD
Pramipexole—Anxiety—Dexamethasone—ankylosing spondylitis	0.000474	0.000563	CcSEcCtD
Pramipexole—Anxiety—Betamethasone—ankylosing spondylitis	0.000474	0.000563	CcSEcCtD
Pramipexole—Discomfort—Betamethasone—ankylosing spondylitis	0.00047	0.000559	CcSEcCtD
Pramipexole—Discomfort—Dexamethasone—ankylosing spondylitis	0.00047	0.000559	CcSEcCtD
Pramipexole—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000469	0.000557	CcSEcCtD
Pramipexole—Pain—Prednisolone—ankylosing spondylitis	0.000468	0.000556	CcSEcCtD
Pramipexole—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000464	0.000551	CcSEcCtD
Pramipexole—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000462	0.000548	CcSEcCtD
Pramipexole—Vision blurred—Prednisone—ankylosing spondylitis	0.000459	0.000545	CcSEcCtD
Pramipexole—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000458	0.000544	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.000458	0.000544	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.000457	0.000543	CcSEcCtD
Pramipexole—Oedema—Betamethasone—ankylosing spondylitis	0.000456	0.000542	CcSEcCtD
Pramipexole—Oedema—Dexamethasone—ankylosing spondylitis	0.000456	0.000542	CcSEcCtD
Pramipexole—Insomnia—Triamcinolone—ankylosing spondylitis	0.000455	0.00054	CcSEcCtD
Pramipexole—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000454	0.000539	CcSEcCtD
Pramipexole—Infection—Dexamethasone—ankylosing spondylitis	0.000453	0.000538	CcSEcCtD
Pramipexole—Infection—Betamethasone—ankylosing spondylitis	0.000453	0.000538	CcSEcCtD
Pramipexole—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000452	0.000537	CcSEcCtD
Pramipexole—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000451	0.000536	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000451	0.000535	CcSEcCtD
Pramipexole—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00045	0.000535	CcSEcCtD
Pramipexole—Visual impairment—Methotrexate—ankylosing spondylitis	0.00045	0.000535	CcSEcCtD
Pramipexole—Anaemia—Prednisone—ankylosing spondylitis	0.00045	0.000535	CcSEcCtD
Pramipexole—Shock—Dexamethasone—ankylosing spondylitis	0.000449	0.000533	CcSEcCtD
Pramipexole—Shock—Betamethasone—ankylosing spondylitis	0.000449	0.000533	CcSEcCtD
Pramipexole—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000448	0.000533	CcSEcCtD
Pramipexole—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000447	0.000532	CcSEcCtD
Pramipexole—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000447	0.000532	CcSEcCtD
Pramipexole—Agitation—Prednisone—ankylosing spondylitis	0.000447	0.000532	CcSEcCtD
Pramipexole—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000447	0.000531	CcSEcCtD
Pramipexole—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000447	0.000531	CcSEcCtD
Pramipexole—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000445	0.000529	CcSEcCtD
Pramipexole—Tachycardia—Betamethasone—ankylosing spondylitis	0.000445	0.000529	CcSEcCtD
Pramipexole—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000443	0.000526	CcSEcCtD
Pramipexole—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000442	0.000525	CcSEcCtD
Pramipexole—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000441	0.000524	CcSEcCtD
Pramipexole—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000441	0.000524	CcSEcCtD
Pramipexole—Malaise—Prednisone—ankylosing spondylitis	0.000439	0.000522	CcSEcCtD
Pramipexole—Vertigo—Prednisone—ankylosing spondylitis	0.000437	0.00052	CcSEcCtD
Pramipexole—Eye disorder—Methotrexate—ankylosing spondylitis	0.000437	0.000519	CcSEcCtD
Pramipexole—Syncope—Prednisone—ankylosing spondylitis	0.000437	0.000519	CcSEcCtD
Pramipexole—Tinnitus—Methotrexate—ankylosing spondylitis	0.000436	0.000518	CcSEcCtD
Pramipexole—Anorexia—Betamethasone—ankylosing spondylitis	0.000435	0.000517	CcSEcCtD
Pramipexole—Anorexia—Dexamethasone—ankylosing spondylitis	0.000435	0.000517	CcSEcCtD
Pramipexole—Urticaria—Prednisolone—ankylosing spondylitis	0.000434	0.000516	CcSEcCtD
Pramipexole—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000434	0.000515	CcSEcCtD
Pramipexole—Fatigue—Triamcinolone—ankylosing spondylitis	0.000433	0.000515	CcSEcCtD
Pramipexole—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000433	0.000514	CcSEcCtD
Pramipexole—Pain—Triamcinolone—ankylosing spondylitis	0.00043	0.000511	CcSEcCtD
Pramipexole—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000428	0.000508	CcSEcCtD
Pramipexole—Hypotension—Dexamethasone—ankylosing spondylitis	0.000426	0.000506	CcSEcCtD
Pramipexole—Hypotension—Betamethasone—ankylosing spondylitis	0.000426	0.000506	CcSEcCtD
Pramipexole—Angiopathy—Methotrexate—ankylosing spondylitis	0.000424	0.000504	CcSEcCtD
Pramipexole—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000422	0.000502	CcSEcCtD
Pramipexole—Convulsion—Prednisone—ankylosing spondylitis	0.000422	0.000501	CcSEcCtD
Pramipexole—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000421	0.0005	CcSEcCtD
Pramipexole—Hypertension—Prednisone—ankylosing spondylitis	0.00042	0.000499	CcSEcCtD
Pramipexole—Chills—Methotrexate—ankylosing spondylitis	0.000419	0.000498	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.000416	0.000494	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.000416	0.000494	CcSEcCtD
Pramipexole—Arthralgia—Prednisone—ankylosing spondylitis	0.000414	0.000492	CcSEcCtD
Pramipexole—Myalgia—Prednisone—ankylosing spondylitis	0.000414	0.000492	CcSEcCtD
Pramipexole—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000414	0.000492	CcSEcCtD
Pramipexole—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000413	0.000491	CcSEcCtD
Pramipexole—Anxiety—Prednisone—ankylosing spondylitis	0.000413	0.000491	CcSEcCtD
Pramipexole—Alopecia—Methotrexate—ankylosing spondylitis	0.000413	0.000491	CcSEcCtD
Pramipexole—Insomnia—Dexamethasone—ankylosing spondylitis	0.000413	0.00049	CcSEcCtD
Pramipexole—Insomnia—Betamethasone—ankylosing spondylitis	0.000413	0.00049	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000412	0.000489	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00041	0.000487	CcSEcCtD
Pramipexole—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00041	0.000487	CcSEcCtD
Pramipexole—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00041	0.000487	CcSEcCtD
Pramipexole—Discomfort—Prednisone—ankylosing spondylitis	0.000409	0.000487	CcSEcCtD
Pramipexole—Mental disorder—Methotrexate—ankylosing spondylitis	0.000409	0.000486	CcSEcCtD
Pramipexole—Malnutrition—Methotrexate—ankylosing spondylitis	0.000407	0.000483	CcSEcCtD
Pramipexole—Erythema—Methotrexate—ankylosing spondylitis	0.000407	0.000483	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000403	0.000479	CcSEcCtD
Pramipexole—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000402	0.000477	CcSEcCtD
Pramipexole—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000402	0.000477	CcSEcCtD
Pramipexole—Urticaria—Triamcinolone—ankylosing spondylitis	0.000399	0.000475	CcSEcCtD
Pramipexole—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000399	0.000474	CcSEcCtD
Pramipexole—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000398	0.000473	CcSEcCtD
Pramipexole—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000397	0.000472	CcSEcCtD
Pramipexole—Oedema—Prednisone—ankylosing spondylitis	0.000397	0.000472	CcSEcCtD
Pramipexole—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000397	0.000471	CcSEcCtD
Pramipexole—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000397	0.000471	CcSEcCtD
Pramipexole—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000397	0.000471	CcSEcCtD
Pramipexole—Infection—Prednisone—ankylosing spondylitis	0.000395	0.000469	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000394	0.000468	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000394	0.000468	CcSEcCtD
Pramipexole—Back pain—Methotrexate—ankylosing spondylitis	0.000394	0.000468	CcSEcCtD
Pramipexole—Fatigue—Betamethasone—ankylosing spondylitis	0.000393	0.000467	CcSEcCtD
Pramipexole—Fatigue—Dexamethasone—ankylosing spondylitis	0.000393	0.000467	CcSEcCtD
Pramipexole—Shock—Prednisone—ankylosing spondylitis	0.000391	0.000464	CcSEcCtD
Pramipexole—Pain—Dexamethasone—ankylosing spondylitis	0.00039	0.000464	CcSEcCtD
Pramipexole—Pain—Betamethasone—ankylosing spondylitis	0.00039	0.000464	CcSEcCtD
Pramipexole—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00039	0.000463	CcSEcCtD
Pramipexole—Tachycardia—Prednisone—ankylosing spondylitis	0.000388	0.000461	CcSEcCtD
Pramipexole—Skin disorder—Prednisone—ankylosing spondylitis	0.000386	0.000459	CcSEcCtD
Pramipexole—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000384	0.000456	CcSEcCtD
Pramipexole—Vision blurred—Methotrexate—ankylosing spondylitis	0.000383	0.000456	CcSEcCtD
Pramipexole—Anorexia—Prednisone—ankylosing spondylitis	0.000379	0.00045	CcSEcCtD
Pramipexole—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000377	0.000448	CcSEcCtD
Pramipexole—Anaemia—Methotrexate—ankylosing spondylitis	0.000376	0.000447	CcSEcCtD
Pramipexole—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000376	0.000447	CcSEcCtD
Pramipexole—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000376	0.000447	CcSEcCtD
Pramipexole—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000373	0.000443	CcSEcCtD
Pramipexole—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000373	0.000443	CcSEcCtD
Pramipexole—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00037	0.00044	CcSEcCtD
Pramipexole—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00037	0.000439	CcSEcCtD
Pramipexole—Malaise—Methotrexate—ankylosing spondylitis	0.000367	0.000436	CcSEcCtD
Pramipexole—Vertigo—Methotrexate—ankylosing spondylitis	0.000366	0.000434	CcSEcCtD
Pramipexole—Leukopenia—Methotrexate—ankylosing spondylitis	0.000364	0.000433	CcSEcCtD
Pramipexole—Urticaria—Betamethasone—ankylosing spondylitis	0.000362	0.000431	CcSEcCtD
Pramipexole—Urticaria—Dexamethasone—ankylosing spondylitis	0.000362	0.000431	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.000362	0.00043	CcSEcCtD
Pramipexole—Dizziness—Prednisolone—ankylosing spondylitis	0.000362	0.00043	CcSEcCtD
Pramipexole—Asthenia—Triamcinolone—ankylosing spondylitis	0.000361	0.000429	CcSEcCtD
Pramipexole—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000361	0.000428	CcSEcCtD
Pramipexole—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000361	0.000428	CcSEcCtD
Pramipexole—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000361	0.000428	CcSEcCtD
Pramipexole—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000361	0.000428	CcSEcCtD
Pramipexole—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00036	0.000428	CcSEcCtD
Pramipexole—Insomnia—Prednisone—ankylosing spondylitis	0.000359	0.000427	CcSEcCtD
Pramipexole—Paraesthesia—Prednisone—ankylosing spondylitis	0.000357	0.000424	CcSEcCtD
Pramipexole—Pruritus—Triamcinolone—ankylosing spondylitis	0.000356	0.000423	CcSEcCtD
Pramipexole—Cough—Methotrexate—ankylosing spondylitis	0.000355	0.000422	CcSEcCtD
Pramipexole—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000355	0.000422	CcSEcCtD
Pramipexole—Convulsion—Methotrexate—ankylosing spondylitis	0.000353	0.000419	CcSEcCtD
Pramipexole—Dyspepsia—Prednisone—ankylosing spondylitis	0.00035	0.000416	CcSEcCtD
Pramipexole—Arthralgia—Methotrexate—ankylosing spondylitis	0.000346	0.000412	CcSEcCtD
Pramipexole—Myalgia—Methotrexate—ankylosing spondylitis	0.000346	0.000412	CcSEcCtD
Pramipexole—Chest pain—Methotrexate—ankylosing spondylitis	0.000346	0.000412	CcSEcCtD
Pramipexole—Decreased appetite—Prednisone—ankylosing spondylitis	0.000345	0.00041	CcSEcCtD
Pramipexole—Rash—Prednisolone—ankylosing spondylitis	0.000345	0.00041	CcSEcCtD
Pramipexole—Dermatitis—Prednisolone—ankylosing spondylitis	0.000344	0.000409	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000344	0.000409	CcSEcCtD
Pramipexole—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000343	0.000408	CcSEcCtD
Pramipexole—Fatigue—Prednisone—ankylosing spondylitis	0.000343	0.000407	CcSEcCtD
Pramipexole—Headache—Prednisolone—ankylosing spondylitis	0.000343	0.000407	CcSEcCtD
Pramipexole—Discomfort—Methotrexate—ankylosing spondylitis	0.000342	0.000407	CcSEcCtD
Pramipexole—Constipation—Prednisone—ankylosing spondylitis	0.00034	0.000404	CcSEcCtD
Pramipexole—Confusional state—Methotrexate—ankylosing spondylitis	0.000335	0.000398	CcSEcCtD
Pramipexole—Dizziness—Triamcinolone—ankylosing spondylitis	0.000332	0.000395	CcSEcCtD
Pramipexole—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000332	0.000394	CcSEcCtD
Pramipexole—Infection—Methotrexate—ankylosing spondylitis	0.00033	0.000392	CcSEcCtD
Pramipexole—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000327	0.000389	CcSEcCtD
Pramipexole—Asthenia—Dexamethasone—ankylosing spondylitis	0.000327	0.000389	CcSEcCtD
Pramipexole—Asthenia—Betamethasone—ankylosing spondylitis	0.000327	0.000389	CcSEcCtD
Pramipexole—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000326	0.000387	CcSEcCtD
Pramipexole—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000325	0.000386	CcSEcCtD
Pramipexole—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000325	0.000386	CcSEcCtD
Pramipexole—Nausea—Prednisolone—ankylosing spondylitis	0.000325	0.000386	CcSEcCtD
Pramipexole—Pruritus—Betamethasone—ankylosing spondylitis	0.000323	0.000383	CcSEcCtD
Pramipexole—Pruritus—Dexamethasone—ankylosing spondylitis	0.000323	0.000383	CcSEcCtD
Pramipexole—Skin disorder—Methotrexate—ankylosing spondylitis	0.000323	0.000383	CcSEcCtD
Pramipexole—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000321	0.000381	CcSEcCtD
Pramipexole—Vomiting—Triamcinolone—ankylosing spondylitis	0.00032	0.00038	CcSEcCtD
Pramipexole—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000319	0.000379	CcSEcCtD
Pramipexole—Rash—Triamcinolone—ankylosing spondylitis	0.000317	0.000377	CcSEcCtD
Pramipexole—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000317	0.000376	CcSEcCtD
Pramipexole—Anorexia—Methotrexate—ankylosing spondylitis	0.000317	0.000376	CcSEcCtD
Pramipexole—Rash—Methylprednisolone—ankylosing spondylitis	0.000316	0.000376	CcSEcCtD
Pramipexole—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000316	0.000375	CcSEcCtD
Pramipexole—Urticaria—Prednisone—ankylosing spondylitis	0.000316	0.000375	CcSEcCtD
Pramipexole—Headache—Triamcinolone—ankylosing spondylitis	0.000315	0.000374	CcSEcCtD
Pramipexole—Headache—Methylprednisolone—ankylosing spondylitis	0.000314	0.000373	CcSEcCtD
Pramipexole—Abdominal pain—Prednisone—ankylosing spondylitis	0.000314	0.000373	CcSEcCtD
Pramipexole—Body temperature increased—Prednisone—ankylosing spondylitis	0.000314	0.000373	CcSEcCtD
Pramipexole—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000312	0.000371	CcSEcCtD
Pramipexole—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000312	0.000371	CcSEcCtD
Pramipexole—Hypotension—Methotrexate—ankylosing spondylitis	0.00031	0.000369	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000303	0.000359	CcSEcCtD
Pramipexole—Dizziness—Dexamethasone—ankylosing spondylitis	0.000302	0.000358	CcSEcCtD
Pramipexole—Dizziness—Betamethasone—ankylosing spondylitis	0.000302	0.000358	CcSEcCtD
Pramipexole—Insomnia—Methotrexate—ankylosing spondylitis	0.0003	0.000357	CcSEcCtD
Pramipexole—Nausea—Triamcinolone—ankylosing spondylitis	0.000299	0.000355	CcSEcCtD
Pramipexole—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000298	0.000354	CcSEcCtD
Pramipexole—Nausea—Methylprednisolone—ankylosing spondylitis	0.000298	0.000354	CcSEcCtD
Pramipexole—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000296	0.000352	CcSEcCtD
Pramipexole—Somnolence—Methotrexate—ankylosing spondylitis	0.000295	0.000351	CcSEcCtD
Pramipexole—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000293	0.000348	CcSEcCtD
Pramipexole—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000292	0.000347	CcSEcCtD
Pramipexole—Vomiting—Dexamethasone—ankylosing spondylitis	0.00029	0.000345	CcSEcCtD
Pramipexole—Vomiting—Betamethasone—ankylosing spondylitis	0.00029	0.000345	CcSEcCtD
Pramipexole—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000289	0.000343	CcSEcCtD
Pramipexole—Rash—Betamethasone—ankylosing spondylitis	0.000288	0.000342	CcSEcCtD
Pramipexole—Rash—Dexamethasone—ankylosing spondylitis	0.000288	0.000342	CcSEcCtD
Pramipexole—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000287	0.000341	CcSEcCtD
Pramipexole—Dermatitis—Betamethasone—ankylosing spondylitis	0.000287	0.000341	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000287	0.000341	CcSEcCtD
Pramipexole—Fatigue—Methotrexate—ankylosing spondylitis	0.000286	0.00034	CcSEcCtD
Pramipexole—Headache—Dexamethasone—ankylosing spondylitis	0.000286	0.00034	CcSEcCtD
Pramipexole—Headache—Betamethasone—ankylosing spondylitis	0.000286	0.00034	CcSEcCtD
Pramipexole—Asthenia—Prednisone—ankylosing spondylitis	0.000285	0.000339	CcSEcCtD
Pramipexole—Pain—Methotrexate—ankylosing spondylitis	0.000284	0.000337	CcSEcCtD
Pramipexole—Pruritus—Prednisone—ankylosing spondylitis	0.000281	0.000334	CcSEcCtD
Pramipexole—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000274	0.000325	CcSEcCtD
Pramipexole—Diarrhoea—Prednisone—ankylosing spondylitis	0.000272	0.000323	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000272	0.000323	CcSEcCtD
Pramipexole—Nausea—Dexamethasone—ankylosing spondylitis	0.000271	0.000322	CcSEcCtD
Pramipexole—Nausea—Betamethasone—ankylosing spondylitis	0.000271	0.000322	CcSEcCtD
Pramipexole—Urticaria—Methotrexate—ankylosing spondylitis	0.000264	0.000313	CcSEcCtD
Pramipexole—Dizziness—Prednisone—ankylosing spondylitis	0.000263	0.000312	CcSEcCtD
Pramipexole—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000262	0.000312	CcSEcCtD
Pramipexole—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000262	0.000312	CcSEcCtD
Pramipexole—Vomiting—Prednisone—ankylosing spondylitis	0.000253	0.0003	CcSEcCtD
Pramipexole—Rash—Prednisone—ankylosing spondylitis	0.000251	0.000298	CcSEcCtD
Pramipexole—Dermatitis—Prednisone—ankylosing spondylitis	0.00025	0.000297	CcSEcCtD
Pramipexole—Headache—Prednisone—ankylosing spondylitis	0.000249	0.000296	CcSEcCtD
Pramipexole—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000245	0.000291	CcSEcCtD
Pramipexole—Asthenia—Methotrexate—ankylosing spondylitis	0.000238	0.000283	CcSEcCtD
Pramipexole—Nausea—Prednisone—ankylosing spondylitis	0.000236	0.00028	CcSEcCtD
Pramipexole—Pruritus—Methotrexate—ankylosing spondylitis	0.000235	0.000279	CcSEcCtD
Pramipexole—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000227	0.00027	CcSEcCtD
Pramipexole—Dizziness—Methotrexate—ankylosing spondylitis	0.00022	0.000261	CcSEcCtD
Pramipexole—Vomiting—Methotrexate—ankylosing spondylitis	0.000211	0.000251	CcSEcCtD
Pramipexole—Rash—Methotrexate—ankylosing spondylitis	0.000209	0.000249	CcSEcCtD
Pramipexole—Dermatitis—Methotrexate—ankylosing spondylitis	0.000209	0.000249	CcSEcCtD
Pramipexole—Headache—Methotrexate—ankylosing spondylitis	0.000208	0.000247	CcSEcCtD
Pramipexole—Nausea—Methotrexate—ankylosing spondylitis	0.000197	0.000234	CcSEcCtD
